Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06071871 |
| Title | A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab as a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma (PORTAL) |
| Acronym | PORTAL |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University College, London |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Kings College Hospital NHS Foundation Trust | RECRUITING | London | United Kingdom | Details | ||
| University College London Hospitals NHS Foundation Trust | RECRUITING | London | United Kingdom | Details | ||
| The Christie NHS Foundation Trust | RECRUITING | Manchester | United Kingdom | Details | ||
| Nottingham University Hospitals NHS Trust | RECRUITING | Nottingham | United Kingdom | Details | ||
| Churchill Hospital | RECRUITING | Oxford | United Kingdom | Details |